Dean Vayser, DPM, FACFAS

Introduction: Bacterial burden >104 CFU/g is known to delay healing1,2 and is challenging to detect in diabetic foot ulcers where co-morbidiites including neuropathy can mask clinical...

Scott Gawlick , DPM;

Alisha Oropallo , MD, FACS, FSVS, FAPWCA, FABWMS;

Dean Vayser , DPM, FACFAS;

08/19/2021

Dehydrated placental allograft (DPA) for the management of diabetic foot ulcers – a randomized controlled trial

Diabetic foot ulcers (DFUs) continue to challenge wound care practitioners. They are prone to infection and increase the risk of lower extremity amputation. The aim of this study was to e...

Michael Leon Sabolinski , MD;

Shawn Cazzell , DPM;

Joseph M. Caporusso , DPM;

Bounthavy Homsombath , MD;

Dean Vayser , DPM, FACFAS;

01/28/2021

Randomized Controlled Trial to Assess the Efficacy of a Single-use Negative Pressure Wound Therapy System, Compared to Traditional Negative Pressure Wound Therapy in the Management of Venous Leg Ulcers and Diabetic Foot Ulcers

Background: High quality clinical evidence on the management of chronic wounds with Negative Pressure Wound Therapy (NPWT) is still scarce for VLU and DFU. Purpose: We aimed to...

Henry Jaimes ;

Robert S. Kirsner , MD, PhD;

Alexander M. Reyzelman , DPM, FACFAS;

Cyaandi R. Dove , DPM;

Dean Vayser , DPM, FACFAS;

08/13/2019

Treatment of Hard-to-Heal Diabetic Foot Ulcers with a Novel Decellularized Hepatic-Derived Wound Matrix: Outcomes from a Prospective Multicenter Trial

Background: One million diabetics in the US will develop diabetic foot ulcers (DFUs); 150,000 ulcers will become chronic. 5-24% of these patients will require amputation. Patients wh...

Deena Horn ;

Payam Rafat ;

Robert Fridman , DPM, FACFAS;

Dean Vayser , DPM, FACFAS;

C. Jake Lambert Jr.;

Carl C. Van Gils ;

07/29/2019

Open-Label Extension Phase Of The Chronic Diabetic Foot Ulcer Multicenter, Controlled, Randomized Clinical Trial Confirms Benefits Of Viable Cryopreserved Placental Membrane For Wound Closure And Reduction Of Adverse Events

Study Objective: In a multicenter, blinded, randomized, controlled clinical trial (RCT), viable cryopreserved placental membrane (vCPM)* applications to chronic DFUs resulted in high...

Dean Vayser , DPM, FACFAS;

James Fulmer ;

David Fried ;

Howard Kashefsky ;

Janaki Nadarajah ;

Karry Ann Shebetka ;

Lawrence A. Lavery , DPM, MPH;

Matthew J. Regulski , DPM, ABMSP, CMET, FAPWH(c);

Tammy M. Owings ;

01/09/2019